(Q54707780)

3 June 2018

http://europepmc.org/abstract/MED/24152157

title

Allopurinol hypersensitivity is primarily mediated by dose-dependent oxypurinol-specific T cell response. (English)

1 reference

3 June 2018

http://europepmc.org/abstract/MED/24152157

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24152157%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

James Yun

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24152157%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Carlo Rodolfo Largiadèr

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24152157%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

author name string

J Mattsson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24152157%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

K Schnyder

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24152157%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

S Fontana

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24152157%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

D Yerly

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24152157%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

publication date

1 November 2013

1 reference

3 June 2018

http://europepmc.org/abstract/MED/24152157

published in

Clinical & Experimental Allergy

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24152157%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24152157%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24152157%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

page(s)

1246-1255

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24152157%20AND%20SRC:MED&resulttype=core&format=json

Efficacy and safety of desensitization to allopurinol following cutaneous reactions

3 June 2020

cites work

1 reference

Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel

21 January 2018

1 reference

HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol

21 January 2018

1 reference

A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs

21 January 2018

1 reference

Pharmacogenetics of drug hypersensitivity

21 January 2018

1 reference

2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia

21 January 2018

1 reference

Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiency

21 January 2018

1 reference

HLA-B58 can help the clinical decision on starting allopurinol in patients with chronic renal insufficiency.

21 January 2018

1 reference

Using allopurinol above the dose based on creatinine clearance is effective and safe in patients with chronic gout, including those with renal impairment

21 January 2018

1 reference

Relation between adverse events associated with allopurinol and renal function in patients with gout

21 January 2018

1 reference

Adverse drug reactions: definitions, diagnosis, and management

21 January 2018

1 reference

Avidity determines T-cell reactivity in abacavir hypersensitivity.

21 January 2018

1 reference

Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire

21 January 2018

1 reference

Abacavir induces loading of novel self-peptides into HLA-B*57: 01: an autoimmune model for HLA-associated drug hypersensitivity

21 January 2018

1 reference

Characterization of the antigen specificity of T-cell clones from piperacillin-hypersensitive patients with cystic fibrosis

21 January 2018

1 reference

Allergic Reaction to Allopurinol with Cross-Reactivity to Oxypurinol

21 January 2018

1 reference

The lymphocyte transformation test in the diagnosis of drug hypersensitivity

21 January 2018

1 reference

Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome

21 January 2018

1 reference

Demonstration of a combined deficiency of xanthine oxidase and aldehyde oxidase in xanthinuric patients not forming oxipurinol

21 January 2018

1 reference

Cross-reactivity in drug hypersensitivity reactions to sulfasalazine and sulfamethoxazole

21 January 2018

1 reference

Hypersensitivity reactions to quinolones

21 January 2018

1 reference

Cross-reactivity patterns of T cells specific for iodinated contrast media

21 January 2018

1 reference

Allopurinol reduces antigen-specific and polyclonal activation of human T cells

21 January 2018

1 reference

Renal clearance of oxipurinol, the chief metabolite of allopurinol

21 January 2018

1 reference